Qiagen NV (NYSE:QGEN)
$ 43.76 -0.39 (-0.88%) Market Cap: 9.73 Bil Enterprise Value: 10.24 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Qiagen NV at Goldman Sachs European Medtech and Healthcare Services Conference Transcript

Sep 07, 2022 / 07:00AM GMT
Release Date Price: $47.52 (+1.54%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Well, thank you, everybody, for joining us today. My name is Matt Sykes. I'm the senior life sciences tools and diagnostics analyst out of the U.S. I have the pleasure of welcoming QIAGEN to our conference this morning. We have Roland Sackers, the Chief Financial Officer; and John Gilardi, the VP of Communications and IR. Roland, John, thanks for joining us today.

Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board

Thanks for having us.

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

So maybe if we just let you kind of set the stage a little bit, talk about the most recent quarter and your expectations for the rest of the year.

Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board

Yes. Happy to do so. And yes, most of you are familiar faces. So I'm going to keep it brief and looking on the number of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot